Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Novavax, Inc. (NVAX)

51.89   3.91 (8.15%) 05-16 07:22
Open: 49.42 Pre. Close: 47.98
High: 52.75 Low: 48.53
Volume: 6,144,364 Market Cap: 4,054(M)
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 52.82 - 53.03 53.03 - 53.24
Low: 48.03 - 48.25 48.25 - 48.47
Close: 51.51 - 51.88 51.88 - 52.23

Technical analysis

as of: 2022-05-13 4:40:14 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 64.31     One year: 74.22
Support: Support1: 41.33    Support2: 34.38
Resistance: Resistance1: 55.06    Resistance2: 63.54
Pivot: 51.64
Moving Average: MA(5): 49.98     MA(20): 51.67
MA(100): 85.12     MA(250): 150.84
MACD: MACD(12,26): -3.7     Signal(9): -4.3
Stochastic oscillator: %K(14,3): 28     %D(3): 32.3
RSI: RSI(14): 45.7
52-week: High: 277.79  Low: 41.33
Average Vol(K): 3-Month: 4,607 (K)  10-Days: 7,101 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ NVAX ] has closed below upper band by 48.9%. Bollinger Bands are 41.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 14 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 11 May 2022
Novavax stock slips 21% as B. Riley cuts price target after Q1 earnings miss (NASDAQ:NVAX) - Seeking Alpha

Tue, 10 May 2022
NVAX Stock Crashes As Covid Vaccine Sales, Profit Lag Expectations - Investor's Business Daily

Tue, 10 May 2022
Stocks making the biggest moves in the premarket: Peloton, Novavax, Vroom and more - CNBC

Tue, 10 May 2022
Pre-market Movers: UPST, FF, NVAX, KOSS, DTST… - RTTNews

Mon, 09 May 2022
Check Out What Whales Are Doing With NVAX - Benzinga - Benzinga

Wed, 04 May 2022
What's Happening With Novavax Stock? - Forbes

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 76 (M)
% Held by Insiders 7.588e+007 (%)
% Held by Institutions 0.5 (%)
Shares Short 9,600 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -1.67e+009
EPS Est Next Qtl -0.16
EPS Est This Year -0.63
EPS Est Next Year -0.56
Book Value (p.s.) 0
Profit Margin (%) -152.2
Operating Margin (%) -147.2
Return on Assets (ttm) -50.7
Return on Equity (ttm) -1
Qtrly Rev. Growth 1.15e+009
Gross Profit (p.s.) -14.65
Sales Per Share 189.8
EBITDA (p.s.) -9.92857e+008
Qtrly Earnings Growth -15
Operating Cash Flow 0 (M)
Levered Free Cash Flow 323 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0.27
Price to Cash Flow 11.22

Stock Dividends

Dividend 0
Forward Dividend 9.47e+006
Dividend Yield 0%
Dividend Pay Date 2019-05-09
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.